Format
Sort by
Items per page

Send to

Choose Destination

Links from PubChem Compound

Items: 1 to 20 of 6573

1.

Probing the Oncolytic and Chemosensitizing Effects of Dihydrotanshinone in an In Vitro Glioblastoma Model.

Kumar V, Radin D, Leonardi D.

Anticancer Res. 2017 Nov;37(11):6025-6030.

PMID:
29061781
2.

HB-EGF is associated with DNA damage and Mcl-1 turnover in human glioma cell lines treated by Temozolomide.

Séry Q, Rabé M, Oliver L, Vallette FM, Gratas C.

Biochem Biophys Res Commun. 2017 Dec 2;493(4):1377-1383. doi: 10.1016/j.bbrc.2017.09.162. Epub 2017 Sep 29.

PMID:
28970067
3.

Classic Hodgkin lymphoma in pelvis: A case report highlights diagnosis and treatment challenges.

Tang F, Min L, Ye Y, Tang B, Zhou Y, Zhang W, Tu C.

Medicine (Baltimore). 2017 Sep;96(39):e8196. doi: 10.1097/MD.0000000000008196.

4.

Stress stimuli induce cancer-stemness gene expression via Sp1 activation leading to therapeutic resistance in glioblastoma.

Chang KY, Huang CT, Hsu TI, Hsu CC, Liu JJ, Chuang CK, Hung JJ, Chang WC, Tsai KK, Chuang JY.

Biochem Biophys Res Commun. 2017 Nov 4;493(1):14-19. doi: 10.1016/j.bbrc.2017.09.095. Epub 2017 Sep 19.

PMID:
28939040
5.

Children and Adolescent Hodgkin Lymphoma in Argentina: Long-term Results After Combined ABVD and Restricted Radiotherapy.

Zubizarreta PA, Alfaro E, Guitter M, Sanchez La Rosa C, Galluzzo ML, Millán N, Fiandrino F, Felice MS.

J Pediatr Hematol Oncol. 2017 Nov;39(8):602-608. doi: 10.1097/MPH.0000000000000943.

PMID:
28902084
6.

Zika virus has oncolytic activity against glioblastoma stem cells.

Zhu Z, Gorman MJ, McKenzie LD, Chai JN, Hubert CG, Prager BC, Fernandez E, Richner JM, Zhang R, Shan C, Tycksen E, Wang X, Shi PY, Diamond MS, Rich JN, Chheda MG.

J Exp Med. 2017 Oct 2;214(10):2843-2857. doi: 10.1084/jem.20171093. Epub 2017 Sep 5. Erratum in: J Exp Med. 2017 Sep 15;:.

PMID:
28874392
7.

Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine.

Demetri GD, Schöffski P, Grignani G, Blay JY, Maki RG, Van Tine BA, Alcindor T, Jones RL, D'Adamo DR, Guo M, Chawla S.

J Clin Oncol. 2017 Oct 20;35(30):3433-3439. doi: 10.1200/JCO.2016.71.6605. Epub 2017 Aug 30.

PMID:
28854066
8.

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.

Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, Drappatz J, O'Rourke DM, Wong M, Hamilton MG, Finocchiaro G, Perry J, Wick W, Green J, He Y, Turner CD, Yellin MJ, Keler T, Davis TA, Stupp R, Sampson JH; ACT IV trial investigators.

Lancet Oncol. 2017 Oct;18(10):1373-1385. doi: 10.1016/S1470-2045(17)30517-X. Epub 2017 Aug 23.

PMID:
28844499
9.

Early-stage Hodgkin lymphoma outcomes after combined modality therapy according to the post-chemotherapy 5-point score: can residual pet-positive disease be cured with radiotherapy alone?

Milgrom SA, Pinnix CC, Chuang H, Oki Y, Akhtari M, Mawlawi O, Garg N, Gunther JR, Reddy JP, Smith GL, Rohren E, Hagemeister FB, Lee HJ, Fayad LE, Dong W, Osborne EM, Abou Yehia Z, Fanale M, Dabaja BS.

Br J Haematol. 2017 Nov;179(3):488-496. doi: 10.1111/bjh.14902. Epub 2017 Aug 18.

PMID:
28832956
10.

AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma.

Chow RD, Guzman CD, Wang G, Schmidt F, Youngblood MW, Ye L, Errami Y, Dong MB, Martinez MA, Zhang S, Renauer P, Bilguvar K, Gunel M, Sharp PA, Zhang F, Platt RJ, Chen S.

Nat Neurosci. 2017 Oct;20(10):1329-1341. doi: 10.1038/nn.4620. Epub 2017 Aug 14.

PMID:
28805815
11.

Successful use of equine anti-thymocyte globulin (ATGAM) for fulminant myocarditis secondary to nivolumab therapy.

Tay RY, Blackley E, McLean C, Moore M, Bergin P, Gill S, Haydon A.

Br J Cancer. 2017 Sep 26;117(7):921-924. doi: 10.1038/bjc.2017.253. Epub 2017 Aug 10.

PMID:
28797029
12.

Blocking LDHA glycolytic pathway sensitizes glioblastoma cells to radiation and temozolomide.

Koukourakis M, Tsolou A, Pouliliou S, Lamprou I, Papadopoulou M, Ilemosoglou M, Kostoglou G, Ananiadou D, Sivridis E, Giatromanolaki A.

Biochem Biophys Res Commun. 2017 Sep 30;491(4):932-938. doi: 10.1016/j.bbrc.2017.07.138. Epub 2017 Jul 26.

PMID:
28756228
13.

TCTP as a therapeutic target in melanoma treatment.

Boia-Ferreira M, Basílio AB, Hamasaki AE, Matsubara FH, Appel MH, Da Costa CRV, Amson R, Telerman A, Chaim OM, Veiga SS, Senff-Ribeiro A.

Br J Cancer. 2017 Aug 22;117(5):656-665. doi: 10.1038/bjc.2017.230. Epub 2017 Jul 27.

PMID:
28751755
14.

Procarbazine, lomustine and vincristine for recurrent high-grade glioma.

Parasramka S, Talari G, Rosenfeld M, Guo J, Villano JL.

Cochrane Database Syst Rev. 2017 Jul 26;7:CD011773. doi: 10.1002/14651858.CD011773.pub2. Review.

PMID:
28744879
15.
16.

Perfusion of surgical cavity wall enhancement in early post-treatment MR imaging may stratify the time-to-progression in glioblastoma.

Park JE, Ryu KH, Kim HS, Kim HW, Shim WH, Jung SC, Choi CG, Kim SJ, Kim JH.

PLoS One. 2017 Jul 21;12(7):e0181933. doi: 10.1371/journal.pone.0181933. eCollection 2017.

17.

Short course radiotherapy concomitant with temozolomide in GBM patients: a phase II study.

Fariselli L, Cuppini L, Gaviani P, Marchetti M, Pinzi V, Milanesi I, Simonetti G, Tramacere I, DiMeco F, Salmaggi A, Silvani A.

Tumori. 2017 Sep 18;103(5):457-463. doi: 10.5301/tj.5000672. Epub 2017 Jul 8.

PMID:
28708230
18.

In vitro nuclear magnetic resonance spectroscopy metabolic biomarkers for the combination of temozolomide with PI3K inhibition in paediatric glioblastoma cells.

Al-Saffar NMS, Agliano A, Marshall LV, Jackson LE, Balarajah G, Sidhu J, Clarke PA, Jones C, Workman P, Pearson ADJ, Leach MO.

PLoS One. 2017 Jul 13;12(7):e0180263. doi: 10.1371/journal.pone.0180263. eCollection 2017.

19.

[Combination Therapy with Radiation, Temozolomide, and Bevacizumab after Partial Tumor Removal in Glioblastoma Patients with Low Performance Status].

Nakao J, Ishikawa E, Matsuda M, Yamamoto T, Takano S, Matsumura A.

Gan To Kagaku Ryoho. 2017 Jun;44(6):495-500. Japanese.

PMID:
28698441
20.

Complete durable response of a pediatric anaplastic oligodendroglioma to temozolomide alone: Case report and review of literature.

Sorge C, Li R, Singh S, Reddy AT, Solomon DA, Perry A, Friedman GK.

Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26708. Epub 2017 Jul 11. Review.

PMID:
28696020

Supplemental Content

Support Center